A Long-Term, Open-Label Study to Assess the Safety and Tolerability of NBI-1065845 as Adjunctive Treatment in Subjects with Major Depressive Disorder [MDD] (NCT06966401)

NBI-1065845-MDD3028

This trial is Coming soon
Registration number NCT06966401
This trial is direct entry only for anyone who completed the 3027 program

Program & service

This trial is being run with the Brain service, and as part of the MAPrc program.

Trial phase

Phase 3

Trial participation type

This trial has been designed for the Clinical Research of a Drug.

Principal investigator

Dr Rebecca Ho

Key inclusion data

NOT RECRUITING: This trial is direct entry only for anyone who completed the 3027 program.

More information

To find out more about this clinical trial, please review full details on the ANZCTR website.

View on ANZCTR

If you would like further details or have any questions about this clinical trial, we encourage you to get in touch with us and a member of our team will be happy to provide you with more information.